These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 18041116)
21. Lawsuits and logistics tie up California's stem-cell funds. Aldhous P Nature; 2005 Mar; 434(7032):427. PubMed ID: 15791221 [No Abstract] [Full Text] [Related]
22. [The embryonic stem cell research agenda in France]. Nau JY Rev Med Suisse; 2007 Dec; 3(138):2921. PubMed ID: 18277770 [No Abstract] [Full Text] [Related]
23. The stem cell debate. Wagner W; Weide U J Contemp Health Law Policy; 2006; 22(2):409-12. PubMed ID: 17117703 [No Abstract] [Full Text] [Related]
24. Demythologizing the stem cell juggernaut. Callahan D Yale J Health Policy Law Ethics; 2009; 9 Suppl():507-22. PubMed ID: 19757718 [No Abstract] [Full Text] [Related]
25. Eligibility of cryopreserved human embryos for stem cell research in Canada. The importance of empirical research in bioethics: the case of human embryo stem cell research. Birdsell J J Obstet Gynaecol Can; 2006 Jan; 28(1):15. PubMed ID: 16533444 [No Abstract] [Full Text] [Related]
30. Human embryonic stem cells leap the barrier. Martin TJ Med J Aust; 2007 Oct; 187(8):477. PubMed ID: 17937651 [No Abstract] [Full Text] [Related]
31. Derivation of GMP raw materials for use in regenerative medicine: hESC-based therapies, progress toward clinical application. Hewitt ZA; Amps KJ; Moore HD Clin Pharmacol Ther; 2007 Oct; 82(4):448-52. PubMed ID: 17687270 [TBL] [Abstract][Full Text] [Related]
32. [Health protection and embryo protection from an ethical-legal perspective. Report of the Bioethics Committee of Rheinland-Pfalz on the need to revise the embryo protection and stem cell laws]. Kress H Ethik Med; 2006 Mar; 18(1):92-9. PubMed ID: 17153256 [No Abstract] [Full Text] [Related]
33. Identifying under- and overperforming countries in research related to human embryonic stem cells. Levine AD Cell Stem Cell; 2008 Jun; 2(6):521-4. PubMed ID: 18522844 [No Abstract] [Full Text] [Related]
34. Words count: how interest in stem cells has made the embryo available--a look at the French law of bioethics. Hennette-Vauchez S Med Law Rev; 2009; 17(1):52-75. PubMed ID: 19091810 [No Abstract] [Full Text] [Related]
35. [The controversy of the use of Stem Cells with therapeutical ends]. Takeuchi CA; Tannuri U Rev Assoc Med Bras (1992); 2006; 52(2):63. PubMed ID: 16767321 [No Abstract] [Full Text] [Related]
36. Derivation of human embryonic stem cell lines from single cells of 4-cell stage embryos: be aware of the risks. Feki A; Hovatta O; Jaconi M Hum Reprod; 2008 Dec; 23(12):2874. PubMed ID: 18854403 [No Abstract] [Full Text] [Related]
37. Delivering on the promise of human stem-cell research. What are the real barriers? Little M; Hall W; Orlandi A EMBO Rep; 2006 Dec; 7(12):1188-92. PubMed ID: 17139291 [No Abstract] [Full Text] [Related]
38. [Report of activities of the Central Ethics Committee for Stem Cell Research. 6th report after implementation of the stem cell regulation for the period 1 December 2007 to 30 November 2008]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):469-73. PubMed ID: 19290484 [No Abstract] [Full Text] [Related]
39. [Human embryonic stem cell research in Germany. The scientific reviewing of applications for the import and use of human embryonic stem cells]. Kiechle M Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Sep; 51(9):961-4. PubMed ID: 18769900 [TBL] [Abstract][Full Text] [Related]